Gene therapy
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
Heart stents may offer alternative to chest pain medication for angina patients
Some patients with chest pain from reduced blood flow to the heart may benefit from having a stent implanted, instead of chest pain medications.
Number of extremely premature babies receiving neonatal care triples
The number of babies born at 22 weeks given respiratory life support in England and Wales increased three-fold after NHS guidelines changed in 2019.
AI stethoscope rolled out to 100 GP clinics to help diagnose heart failure
GP clinics in London and Wales will receive an AI-powered tool as part of a trial to help improve the diagnosis of a deadly heart condition.
Statin benefits patients with severe COVID-19 while vitamin C is ‘ineffective'
A common cholesterol-lowering drug may improve outcomes for critically ill patients with COVID-19, while high dose vitamin C is ineffective.
Major study shows new insights into lasting impacts of COVID‐19 on UK population
Tens of thousands of people in England may have lasting symptoms from COVID‐19 more than a year
after infection, new analysis reveals.
Surgery-free brain stimulation could provide new treatment for dementia
A new form of deep brain stimulation offers hope for an alternative treatment option for dementia, without the need for surgery.
Gene-edited chickens show promise in fight against bird flu
Scientists have successfully used gene editing techniques to limit the spread of bird flu in chickens.
New multi-million research projects announced to tackle future disease threats
Imperial scientists are among those to lead ambitious new UK-based research to kickstart future vaccine development.
Imperial partners in UK’s first total-body PET platform for drug discovery
Imperial researchers are partners in a UK initiative to improve clinical imaging for research and the development of new treatments.